JP2025535447A5 - - Google Patents

Info

Publication number
JP2025535447A5
JP2025535447A5 JP2025522938A JP2025522938A JP2025535447A5 JP 2025535447 A5 JP2025535447 A5 JP 2025535447A5 JP 2025522938 A JP2025522938 A JP 2025522938A JP 2025522938 A JP2025522938 A JP 2025522938A JP 2025535447 A5 JP2025535447 A5 JP 2025535447A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
sequence shown
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025522938A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025535447A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/125253 external-priority patent/WO2024083161A1/en
Publication of JP2025535447A publication Critical patent/JP2025535447A/ja
Publication of JP2025535447A5 publication Critical patent/JP2025535447A5/ja
Pending legal-status Critical Current

Links

JP2025522938A 2022-10-19 2023-10-18 抗体-薬物コンジュゲート、その調製方法および使用 Pending JP2025535447A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CNPCT/CN2022/126273 2022-10-19
CN2022126273 2022-10-19
CN2023118363 2023-09-12
CNPCT/CN2023/118363 2023-09-12
PCT/CN2023/125253 WO2024083161A1 (en) 2022-10-19 2023-10-18 Antibody-drug conjugate, preparation method and use thereof

Publications (2)

Publication Number Publication Date
JP2025535447A JP2025535447A (ja) 2025-10-24
JP2025535447A5 true JP2025535447A5 (cg-RX-API-DMAC7.html) 2025-11-04

Family

ID=90737003

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025522938A Pending JP2025535447A (ja) 2022-10-19 2023-10-18 抗体-薬物コンジュゲート、その調製方法および使用

Country Status (10)

Country Link
US (1) US20260166169A1 (cg-RX-API-DMAC7.html)
EP (1) EP4605015A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025535447A (cg-RX-API-DMAC7.html)
KR (1) KR20250080903A (cg-RX-API-DMAC7.html)
CN (1) CN120091834A (cg-RX-API-DMAC7.html)
AU (1) AU2023362056A1 (cg-RX-API-DMAC7.html)
IL (1) IL320035A (cg-RX-API-DMAC7.html)
MX (1) MX2025004492A (cg-RX-API-DMAC7.html)
TW (1) TW202430221A (cg-RX-API-DMAC7.html)
WO (1) WO2024083161A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026037321A1 (en) * 2024-08-13 2026-02-19 Lepu Biopharma Co., Ltd. Compounds, compositions and methods
CN120369658B (zh) * 2025-06-26 2025-08-29 凯莱英生命科学技术(天津)有限公司 测定抗体偶联药物中毒素连接子的消光系数的方法及检测抗体偶联药物中药物抗体偶联比的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3700577A1 (en) * 2017-10-23 2020-09-02 Mablink Bioscience Ligand-drug-conjugate comprising a single molecular weight polysarcosine
TWI851634B (zh) * 2018-12-21 2024-08-11 大陸商沐特圖公司 Muc18特異性抗體
TWI870378B (zh) * 2019-01-28 2025-01-21 大陸商沐特圖公司 Cd44特異性抗體
AU2020279979A1 (en) * 2019-05-20 2021-11-25 Les Laboratoires Servier Mcl-1 inhibitor antibody-drug conjugates and methods of use
EP4161966A1 (en) * 2020-06-05 2023-04-12 Eisai R&D Management Co., Ltd. Anti-bcma antibody-drug conjugates and methods of use

Similar Documents

Publication Publication Date Title
JP2021102648A (ja) 抗folr1免疫複合体投与計画
KR102923527B1 (ko) 생체활성 분자 접합체, 이의 제조 방법 및 용도
JP7191938B2 (ja) Igf-1rモノクローナル抗体及びその使用
EP3151865B1 (en) Site-specific conjugation of linker drugs to antibodies and resulting adcs
JP2023512036A5 (cg-RX-API-DMAC7.html)
US20250297004A1 (en) Nectin-4 binding agents
KR20230145162A (ko) 표적 전달 이용을 위한 2가 섬유모세포 활성화 단백질 리간드
KR20210042120A (ko) 항체-약물 콘주게이트와 튜불린 저해제의 조합
US20190298846A1 (en) Cell targeting conjugates
CN120393061A (zh) 放射性免疫缀合物与dna损伤和修复抑制剂组合疗法
US20240366782A1 (en) Means and methods for producing antibody-linker conjugates
WO2021228044A1 (en) Drug conjugates containing alpha-enolase antibodies and uses thereof
TW201905000A (zh) 含有抗globo h抗體之抗體-藥物共軛物及其用途
EP3102242A2 (en) Targeted drug conjugates
WO2025118472A1 (zh) 一种抗met/egfr双特异性抗体及其药物偶联物
JP2025533983A (ja) リンカー-ペイロード化合物、複合体、及びその用途
JP2025535447A (ja) 抗体-薬物コンジュゲート、その調製方法および使用
US20240269313A1 (en) Conjugates comprising a phosphorus(v) moiety and a drug
US20240091372A1 (en) Anti-doppel antibody drug conjugates
WO2025043019A1 (en) Slc4a1 (band 3) binding single domain antibodies for increased blood retention
HK40058007A (en) Site-specific conjugation of linker drugs to antibodies and resulting adcs
WO2026092701A1 (zh) 一种抗体-药物偶联物及其制备方法和用途
TW202506190A (zh) 利用抗muc1抗體-藥物結合物投予的藥劑低敏感性癌之治療方法
KR20250115918A (ko) 항체-약물 접합체 제조를 위한 새로운 캄토테신 유도체-링커 화합물
CN120282803A (zh) 抗体-药物缀合物和dnmt抑制剂的组合